Kevin Lee, CHIEF EXECUTIVE OFFICER at BICYCLE THERAPEUTICS PLC (BCYC), sold 7,805 shares at $3.47 ($27K) on 2026-10-02, disclosed to the SEC on 2026-10-06.
Seasonal sale ($27k) by CHIEF EXECUTIVE OFFICER — this insider has traded BCYC in October in at least three consecutive prior years. Pattern-driven, low signal.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $3.47 | 6,167 | $21K | 78.5% |
| 2 | $3.57 | 1,638 | $6K | 21.5% |
| Total | $3.49 avg | 7,805 | $27K | 100% |
| Filing → |
| BCYC | SELL | 2026-01-06 | $141K | — | Filing → |
| BCYC | SELL | 2025-10-06 | $46K | — | Filing → |
| BCYC | SELL | 2025-07-07 | $40K | — | Filing → |